| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 127, 2738-2743, Copyright © 1990 by Endocrine Society
ARTICLES |
A Bourdeau, F Atmani, B Grosse and M Lieberherr
Centre National de la Recherche Scientifique URA 583, Universite Paris V, Groupe Hospitalier Necker-Enfants Malades, France.
We examined the rapid effects (less than 120 sec) of 1,25(OH)2D3 on membrane phospholipid hydrolysis in porcine parathyroid cells and compared these effects to those produced by extracellular Ca2+. Cells were labeled with [3H]myo-inositol or [14C]arachidonic acid for 3 h, then exposed to various 1,25(OH)2D3 concentrations in 0.5 mM Ca2+ for different time periods or to 2 mM [Ca2+]. Parathyroid cells showed a biphasic increase in diacylglycerol (DAG), monoacylglycerol (MG), phosphatidic acid (PA), and inositol trisphosphate (IP3) in response to 1,25(OH)2D3 (10(-12)-10(-8) M) or to 2 mM [Ca2+]. This effect was rapid (within 5 sec) and dose-dependent, with a maximal stimulation with 10 pM of 1,25(OH)2D3. At this concentration, the first peak of DAG, MG, and IP3 was at 5 sec and reached 176 +/- 9%, 134 +/- 4%, and 154 +/- 13%, respectively vs. basal levels. For PA, the first maximum increase was at 20 sec (130 +/- 6%). At 30 sec MG, PA, and IP3 returned to basal levels, whereas the decrease in DAG was under the basal level (-25 +/- 5%). The second peak reached a maximum at 60 sec for the four products (145 +/- 8%, 119 +/- 5%, 125 +/- 6%, and 175 +/- 20%, respectively) then decreased to basal level at 120 sec. High extracellular Ca2+ (2 mM) and fluoride (5 mM) also produced similar increase in phosphatidylinositol metabolites, except that DAG levels returned to basal level at 30 sec. In conclusion, the present data shows the existence of rapid effects of 1,25(OH)2D3 in porcine parathyroid cells. The short time sequence suggests that they are mediated by a direct interaction with the membrane, possibly through a receptor-mediated process linked to phospholipase C by a G-protein.
This article has been cited by other articles:
![]() |
A. S. Dusso, A. J. Brown, and E. Slatopolsky Vitamin D Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Kim, P. A. Newcomb, C. M. Ulrich, C. L. Keener, J. Bigler, F. M. Farin, R. M. Bostick, and J. D. Potter Vitamin D Receptor Polymorphism and the Risk of Colorectal Adenomas: Evidence of Interaction with Dietary Vitamin D and Calcium Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 869 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Crescioli, M. Maggi, G. B. Vannelli, M. Luconi, R. Salerno, T. Barni, M. Gulisano, G. Forti, and M. Serio Effect of a Vitamin D3 Analogue on Keratinocyte Growth Factor-Induced Cell Proliferation in Benign Prostate Hyperplasia J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2576 - 2583. [Abstract] [Full Text] |
||||
![]() |
I. Nemere, R. Ray, and W. McManus Immunochemical studies on the putative plasmalemmal receptor for 1,25(OH)2D3. I. Chick intestine Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1104 - E1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Brown, A. Dusso, and E. Slatopolsky Vitamin D Am J Physiol Renal Physiol, August 1, 1999; 277(2): F157 - F175. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Song, J. E. Bishop, W. H. Okamura, and A. W. Norman Stimulation of Phosphorylation of Mitogen-Activated Protein Kinase by 1{alpha},25-Dihydroxyvitamin D3 in Promyelocytic NB4 Leukemia Cells: A Structure-Function Study Endocrinology, February 1, 1998; 139(2): 457 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Norman, W. H. Okamura, M. W. Hammond, J. E. Bishop, M. C. Dormanen, R. Bouillon, H. van Baelen, A. L. Ridall, E. Daane, R. Khoury, et al. Comparison of 6-s-cis- and 6-s-trans-Locked Analogs of 1{alpha},25-Dihydroxyvitamin D3 Indicates That the 6-s-cis Conformation Is Preferred for Rapid Nongenomic Biological Responses and That Neither 6-s-cis- nor 6-s-trans-Locked Analogs Are Preferred for Genomic Biological Responses Mol. Endocrinol., September 1, 1997; 11(10): 1518 - 1531. [Abstract] [Full Text] |
||||
![]() |
V. Le Mellay, B. Grosse, and M. Lieberherr Phospholipase C beta and Membrane Action of Calcitriol and Estradiol J. Biol. Chem., May 2, 1997; 272(18): 11902 - 11907. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Slater, M. B. Kelly, Frank. J. Taddeo, J. D. Larkin, M. D. Yeager, J. A. McLane, C. Ho, and C. D. Stubbs Direct Activation of Protein Kinase C by 1alpha,25-Dihydroxyvitamin D(3) J. Biol. Chem., March 24, 1995; 270(12): 6639 - 6643. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |